Tag: gastrointestinal diseases

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 23, 2018

Big Pharma M&A: Shire Reviews Fourth Acquisition Proposal from Takeda

Takeda Pharmaceuticals may become a top global drugmaker with positions in treatments for cancers, gastrointestinal diseases and nervous-system disorders.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 4, 2018

5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...
February 20, 2018

5 Pharmaceutical NASDAQ Micro-Cap Stocks

Many companies are taking advantage of partnerships and M&As, whereas others are looking to maximize their own sales by solely...
February 18, 2018

5 Top NASDAQ Biotech Stocks: HTG in the Lead This Week

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...